Topic

Evkeeza (evinacumab-dgnb)

A collection of 42 issues

How to Get Evkeeza (Evinacumab-dgnb) Covered by Aetna CVS Health in California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Evkeeza Covered by Aetna CVS Health in California Eligibility: Evkeeza requires prior authorization for homozygous familial hypercholesterolemia (HoFH) patients aged 5+ who've failed standard lipid-lowering therapies. Fastest approval path: Submit complete prior authorization through Aetna's Availity portal with genetic testing, LDL-C levels, and
6 min read

How to Get Evkeeza (Evinacumab-dgnb) Covered by Cigna in New Jersey: Prior Authorization, Appeals, and State Protections

Answer Box: Getting Evkeeza Covered by Cigna in New Jersey Evkeeza (evinacumab-dgnb) requires strict prior authorization from Cigna for homozygous familial hypercholesterolemia (HoFH). New Jersey law mandates 72-hour response times for non-urgent requests and 24-hour for urgent cases. First step: Have your specialist submit the Cigna PA form with genetic
7 min read

How to Get Evkeeza (Evinacumab-dgnb) Covered by Humana in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Evkeeza Covered by Humana in New York Evkeeza (evinacumab-dgnb) is covered by Humana Medicare Advantage plans but requires prior authorization. For fastest approval: (1) Your provider submits genetic testing results confirming homozygous familial hypercholesterolemia (HoFH), documented LDL-C levels >400-500 mg/dL, and records of maximally tolerated
6 min read

UnitedHealthcare's Coverage Criteria for Evkeeza in Texas: What Counts as "Medically Necessary"?

Answer Box: Getting Evkeeza Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Evkeeza (evinacumab-dgnb) with strict medical necessity criteria. You'll need documented homozygous familial hypercholesterolemia (HoFH), genetic testing or LDL-C ≥300 mg/dL on maximally tolerated therapy, and evidence of failed standard treatments. First step: Have
6 min read

Renewing Evkeeza (evinacumab-dgnb) Approval with Blue Cross Blue Shield in New Jersey: 2025 Requirements & Timeline

Answer Box: Renewing Evkeeza Coverage in New Jersey Blue Cross Blue Shield (BCBS) requires annual prior authorization renewal for Evkeeza (evinacumab-dgnb) in New Jersey. Key requirements include documented HoFH diagnosis, updated LDL-C labs showing ongoing need, and evidence of maximum tolerated lipid-lowering therapy. Start renewal 60-90 days before expiration. If
6 min read